182 related articles for article (PubMed ID: 19760196)
41. Rare but real: management of small bowel adenocarcinoma.
Overman MJ
Am Soc Clin Oncol Educ Book; 2013; ():189-93. PubMed ID: 23714497
[TBL] [Abstract][Full Text] [Related]
42. Second-line Chemotherapy for Previously Treated Metastatic Small Bowel Adenocarcinoma: A Retrospective Analysis.
Nakazawa T; Narita Y; Kumanishi R; Ogata T; Matsubara Y; Nozawa K; Kato K; Honda K; Masuishi T; Bando H; Kadowaki S; Ando M; Hara K; Tajika M; Muro K
Anticancer Res; 2021 Oct; 41(10):5147-5155. PubMed ID: 34593466
[TBL] [Abstract][Full Text] [Related]
43. Rectal carcinoma and multiple gastrointestinal stromal tumors (GIST) of the small intestine in a patient with neurofibromatosis type 1: a case report.
Hakozaki Y; Sameshima S; Tatsuoka T; Okuyama T; Yamagata Y; Noie T; Oya M; Fujii A; Ueda Y; Shimura C; Katagiri K
World J Surg Oncol; 2017 Aug; 15(1):160. PubMed ID: 28835241
[TBL] [Abstract][Full Text] [Related]
44. Primary small bowel adenocarcinoma: current view on clinical features, risk and prognostic factors, treatment and outcome.
Lech G; Korcz W; Kowalczyk E; Słotwiński R; Słodkowski M
Scand J Gastroenterol; 2017 Nov; 52(11):1194-1202. PubMed ID: 28737049
[TBL] [Abstract][Full Text] [Related]
45. Chemotherapy in small bowel adenocarcinoma: 10-year experience of the British Columbia Cancer Agency.
Czaykowski P; Hui D
Clin Oncol (R Coll Radiol); 2007 Mar; 19(2):143-9. PubMed ID: 17355111
[TBL] [Abstract][Full Text] [Related]
46. Suggestion of added value by bevacizumab to chemotherapy in patients with unresectable or recurrent small bowel cancer.
Takayoshi K; Kusaba H; Uenomachi M; Mitsugi K; Makiyama C; Makiyama A; Uchino K; Shirakawa T; Shibata Y; Shinohara Y; Inadomi K; Tsuchihashi K; Arita S; Ariyama H; Esaki T; Akashi K; Baba E
Cancer Chemother Pharmacol; 2017 Aug; 80(2):333-342. PubMed ID: 28653251
[TBL] [Abstract][Full Text] [Related]
47. Prognostic Role of Body Mass Index in Advanced Small Bowel Adenocarcinoma Patients Receiving Palliative Chemotherapy.
Lee DW; Lee KH; Kim TY; Han SW; Oh DY; Im SA; Kim TY; Bang YJ
Nutr Cancer; 2016 Jul; 68(5):750-5. PubMed ID: 27282771
[TBL] [Abstract][Full Text] [Related]
48. Changing patterns of prognosticators during 15-year follow-up of advanced gastric cancer after radical gastrectomy and adjuvant chemotherapy: a 15-year follow-up study at a single korean institute.
Moon YW; Jeung HC; Rha SY; Yoo NC; Roh JK; Noh SH; Kim BS; Chung HC
Ann Surg Oncol; 2007 Oct; 14(10):2730-7. PubMed ID: 17632757
[TBL] [Abstract][Full Text] [Related]
49. Meta-analysis of postoperative adjuvant therapy for small bowel adenocarcinoma.
Ye X; Zhang G; Chen H; Li Y
PLoS One; 2018; 13(8):e0200204. PubMed ID: 30096150
[TBL] [Abstract][Full Text] [Related]
50. [Small bowel adenocarcinoma].
Zaanan A; Afchain P; Carrere N; Aparicio T
Gastroenterol Clin Biol; 2010; 34(6-7):371-9. PubMed ID: 20537487
[TBL] [Abstract][Full Text] [Related]
51. Nomograms predict survival of patients with small bowel adenocarcinoma: a SEER-based study.
Zheng Z; Zhou X; Zhang J; Zhao B; Chen C; Liu X; Cao H; Li T; Geng R; Wang W; Li Y
Int J Clin Oncol; 2021 Feb; 26(2):387-398. PubMed ID: 33113018
[TBL] [Abstract][Full Text] [Related]
52. Surgically treated primary malignant tumor of small bowel: a clinical analysis.
Han SL; Cheng J; Zhou HZ; Guo SC; Jia ZR; Wang PF
World J Gastroenterol; 2010 Mar; 16(12):1527-32. PubMed ID: 20333796
[TBL] [Abstract][Full Text] [Related]
53. Prognostic factors of primary small bowel adenocarcinoma: univariate and multivariate analysis.
Wu TJ; Yeh CN; Chao TC; Jan YY; Chen MF
World J Surg; 2006 Mar; 30(3):391-8; discussion 399. PubMed ID: 16479330
[TBL] [Abstract][Full Text] [Related]
54. Combination chemotherapy in advanced small bowel adenocarcinoma.
Locher C; Malka D; Boige V; Lebray P; Elias D; Lasser P; Ducreux M
Oncology; 2005; 69(4):290-4. PubMed ID: 16282708
[TBL] [Abstract][Full Text] [Related]
55. [Malignant tumors of the small intestine. Diagnostic problems and differentiated surgical therapy].
Broll R; Bruch HP; Daniel D; Schiedeck T
Chirurg; 1994 May; 65(5):451-6. PubMed ID: 8050300
[TBL] [Abstract][Full Text] [Related]
56. R1 rectal resection: look up and don't look down.
Tilly C; Lefèvre JH; Svrcek M; Shields C; Fléjou JF; Tiret E; Parc Y
Ann Surg; 2014 Nov; 260(5):794-9; discussion 799-800. PubMed ID: 25379851
[TBL] [Abstract][Full Text] [Related]
57. Endoscopic Detection of Small Bowel Dysplasia and Adenocarcinoma in Crohn's Disease: A Prospective Cohort-Study in High-Risk Patients.
Simon M; Cosnes J; Gornet JM; Seksik P; Stefanescu C; Blain A; Pariente B; Nancey S; Vuitton L; Nachury M; D'Haens G; Filippi J; Chevret S; Laharie D;
J Crohns Colitis; 2017 Jan; 11(1):47-52. PubMed ID: 27405958
[TBL] [Abstract][Full Text] [Related]
58. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
[TBL] [Abstract][Full Text] [Related]
59. [Clinical Experience with 13 Cases of Primary Small Bowel Adenocarcinoma].
Fujino M; Oda K; Shimizu Y; Tonouchi A; Nobumoto D; Ando K
Gan To Kagaku Ryoho; 2020 Dec; 47(13):2213-2215. PubMed ID: 33468911
[TBL] [Abstract][Full Text] [Related]
60. Characteristics and outcome of patients with small bowel adenocarcinoma (SBA).
Teufel A; Meindl-Beinker NM; Hösel P; Gerken M; Roig A; Ebert MP; Herr W; Scheiter A; Pauer A; Schlitt HJ; Klinkhammer-Schalke M
J Cancer Res Clin Oncol; 2023 Jul; 149(8):4579-4590. PubMed ID: 36163558
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
